Enzar 10000 Capsule contains Pancreatin 10000 PFU, a combination of digestive enzymes including amylase, lipase, and protease, designed to aid in the digestion of carbohydrates, fats, and proteins respectively. This medication is primarily indicated for patients with pancreatic exocrine insufficiency resulting from conditions such as chronic pancreatitis, cystic fibrosis, pancreatic surgery, or other disorders leading to inadequate enzyme production. By supplementing endogenous enzymes, Enzar 10000 Capsule facilitates improved nutrient absorption, thereby alleviating symptoms like malabsorption, steatorrhea, bloating, and abdominal discomfort. The dosage and administration should be tailored according to the severity of enzyme deficiency, dietary fat content, and clinical response, typically taken with meals or snacks to optimize digestive efficacy. Contraindications include known hypersensitivity to pancreatin or any of the capsule components. Caution is advised in patients with allergies to pork products, as pancreatin is derived from porcine sources. Common adverse effects are generally mild and may include gastrointestinal disturbances such as nausea, abdominal pain, or diarrhea. Enzar 10000 Capsule should be used under medical supervision, with regular monitoring to adjust dosage and assess therapeutic outcomes. It is not intended for the treatment of acute pancreatitis or pancreatic infections.